Sensei Biotherapeutics Inc. (NASDAQ: SNSE) Stock Information | RedChip

Sensei Biotherapeutics Inc. (NASDAQ: SNSE) Listen to this Section


$0.63
+0.0250 ( +4.11% ) 15.0K

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

Market Data


Open


$0.63

Previous close


$0.61

Volume


15.0K

Market cap


$15.47M

Day range


$0.58 - $0.63

52 week range


$0.51 - $1.94

Insider Ownership Transactions

Total Amount Purchased: -161,518.00 | $ -102,402.41

Date Type Amount Purchased Purchaser
2024-06-13 Sale -19000.00 RINGO WILLIAM R
2024-06-13 Sale -19000.00 Vojta Deneen
2024-06-13 Sale -19000.00 Cambrian BioPharma Inc
2024-06-13 Sale -19000.00 Peyer James
2024-06-13 Sale -19000.00 English Jessie
2024-06-13 Sale -19000.00 Holmen Bob
2024-06-13 Sale -19000.00 Humer Kristian
2024-06-13 Sale -19000.00 RICKS THOMAS G
2024-02-16 Sale -3627.00 Colgan Erin
2024-02-16 Sale -5891.00 Celebi John

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 06, 2024
10-q Quarterly Reports 70 Aug 06, 2024
8-k 8K-related 14 Jul 12, 2024
8-k 8K-related 14 Jun 27, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
8-k 8K-related 14 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.